4/A//SEC Filing
Nelson Christopher M. 4/A
Accession 0001493152-24-006714
CIK 0001310527other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:43 PM ET
Size
7.6 KB
Accession
0001493152-24-006714
Insider Transaction Report
Form 4/AAmended
Nelson Christopher M.
DirectorCEO
Transactions
- Conversion
Common Stock
2024-02-06$3.00/sh+8,683$26,049→ 182,000 total - Conversion
Series B Convertible Preferred Stock
2024-02-06→ 0 totalExercise: $3.00From: 2021-01-27→ Common Stock (8,683 underlying)
Footnotes (1)
- [F1]Correction to footnote: On February 13, 2024, the reporting person filed a Form 4 which inadvertently reported in footnote 1 that the date of the Exchange Agreements between the Issuer and all the Series B stockholders was 11/18/2023. It is hereby corrected that the Exchange Agreements were entered into between the dates of 10/16/2023 and 10/23/2023.
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001529012
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:43 PM ET
- Size
- 7.6 KB